Collegium Pharmaceutical Inc. (COLL)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 2 |
| Ownership rank: | 361 |
| % of all portfolios: | 0.009% |
| Hold Price * : | $38.82 |
| History | Portfolio Manager | Activity ▲ | Share change | % change to portfolio | |
| Q1 2024 | |||||
| ≡ | Third Avenue Management | Add 30.08% | 25,000 | 0.15 | |
| ≡ | Lee Ainslie - Maverick Capital | Buy | 8,873 | 0.01 | |
| Q4 2023 | |||||
| ≡ | Third Avenue Management | Buy | 83,120 | 0.42 | |
| Q3 2023 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 10,401 | 0.00 | |
| Q2 2023 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 7.92% | 895 | 0.00 | |
| Q1 2023 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 5.17% | 555 | 0.00 | |
| Q4 2022 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 27.09% | 3,991 | 0.00 | |
| Q3 2022 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 14,732 | 0.01 | |
| Q3 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 33,751 | 0.01 | |
| Q2 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 33,751 | 0.01 | |
| Q1 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 6,926 | 0.00 | |
| Q4 2020 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 6,926 | 0.00 | |
| Q2 2019 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 395,080 | 0.08 | |
| Q1 2019 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 395,080 | 0.08 | |
| Q4 2018 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 421,993 | 0.08 | |
| Q3 2018 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 0.61% | 2,597 | 0.00 | |
| Q2 2018 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 424,590 | 0.12 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.